Ultra-Aggressive Stock Screening Report
Trading Period: December 8-19, 2025
Target: 3x SPY Performance | Max Loss: 10% | Budget: EUR 1,271.97
Screening Date: December 6, 2025
Risk Profile: ULTRA-AGGRESSIVE
Executive Summary
After comprehensive screening using multiple data sources (yfinance, Finnhub, web research) and quantitative factor modeling, I have identified 12 high-conviction candidates for the 2-week ultra-aggressive trading strategy. The final ranking combines fundamental screening scores with quantitative factor analysis (momentum, volatility, short squeeze potential, and sentiment).
Key Finding: FCEL (FuelCell Energy) was EXCLUDED due to earnings release on December 18, 2025 - which falls within our trading window.
Final Ranked Recommendations
Tier 1: STRONG BUY (Quant Score 4.0+)
| Rank |
Ticker |
Company |
Price |
Beta |
RSI |
Short% |
Quant Score |
Strategy |
| 1 |
ONDS |
Ondas Holdings |
$9.07 |
2.36 |
60.1 |
22.95% |
4.20 |
Momentum/Squeeze |
| 2 |
NVTS |
Navitas Semiconductor |
$9.48 |
3.13 |
67.2 |
33.42% |
4.04 |
Momentum/Squeeze |
Tier 2: BUY (Quant Score 3.5-4.0)
| Rank |
Ticker |
Company |
Price |
Beta |
RSI |
Short% |
Quant Score |
Strategy |
| 3 |
NTLA |
Intellia Therapeutics |
$9.61 |
2.13 |
60.5 |
38.97% |
3.88 |
Short Squeeze |
| 4 |
CLSK |
CleanSpark |
$13.72 |
3.80 |
62.5 |
29.97% |
3.82 |
High Beta/Squeeze |
| 5 |
UPST |
Upstart Holdings |
$46.75 |
2.28 |
67.2 |
29.53% |
3.67 |
AI Fintech/Squeeze |
| 6 |
WULF |
TeraWulf |
$14.50 |
4.31 |
69.1 |
30.87% |
3.61 |
AI Pivot/Squeeze |
Tier 3: SPECULATIVE BUY (Quant Score 3.0-3.5)
| Rank |
Ticker |
Company |
Price |
Beta |
RSI |
Short% |
Quant Score |
Strategy |
| 7 |
BEAM |
Beam Therapeutics |
$27.09 |
2.22 |
67.0 |
22.75% |
3.48 |
Event Catalyst |
| 8 |
SYM |
Symbotic |
$59.70 |
2.11 |
50.9 |
29.79% |
3.41 |
High Volatility |
| 9 |
MARA |
MARA Holdings |
$11.74 |
5.44 |
48.1 |
33.23% |
3.29 |
High Beta/BTC |
| 10 |
BE |
Bloom Energy |
$119.18 |
3.00 |
54.2 |
10.81% |
3.22 |
AI Infrastructure |
| 11 |
HUT |
Hut 8 Corp |
$42.43 |
6.21 |
58.9 |
14.66% |
3.16 |
Extreme Beta |
| 12 |
CRSP |
CRISPR Therapeutics |
$56.88 |
1.73 |
59.3 |
27.31% |
2.98 |
Biotech/Squeeze |
Detailed Candidate Profiles
1. ONDS - Ondas Holdings Inc. (STRONG BUY)
- Sector: Technology (Defense/Drones)
- Price: $9.07 | Beta: 2.36 | RSI: 60.1 | Short Interest: 22.95%
- Quantitative Score: 4.20/5.0 (100th percentile)
- Recent Catalyst: Border drone megadeal announced Dec 3, 2025; $8.2M European airport counter-UAS orders
- Why It Ranks #1:
- 700%+ YTD return with continued momentum (19.66% 1W, 56.11% 1M)
- Multiple recent contract wins create positive news flow
- RSI in optimal range (60.1) with room to run
- Analyst price target $13 from Ladenburg Thalmann
- Risk: Extended after massive rally; profit-taking possible
- Next Earnings: March 12, 2026 (NO conflict)
2. NVTS - Navitas Semiconductor (STRONG BUY)
- Sector: Semiconductors (GaN/SiC)
- Price: $9.48 | Beta: 3.13 | RSI: 67.2 | Short Interest: 33.42%
- Quantitative Score: 4.04/5.0 (91st percentile)
- Recent Catalyst: Nvidia partnership for AI data centers; 165% YTD gain
- Why It Ranks #2:
- Nvidia partnership validates GaN technology leadership
- Very high short interest (33%+) creates squeeze potential
- Strong momentum (14.22% 1W, 20.92% 1M)
- AI data center power efficiency theme
- Risk: Transitioning business model; insider selling noted
- Next Earnings: February 23, 2026 (NO conflict)
3. NTLA - Intellia Therapeutics (BUY)
- Sector: Biotech (CRISPR/Gene Editing)
- Price: $9.61 | Beta: 2.13 | RSI: 60.5 | Short Interest: 38.97%
- Quantitative Score: 3.88/5.0 (83rd percentile)
- Recent Catalyst: Highest short interest in group (39%); lonvo-z showing 97% attack-free results
- Why It Ranks #3:
- HIGHEST short interest of all candidates = maximum squeeze potential
- Clinical hold on nex-z already priced in (stock near 52-week lows)
- Positive lonvo-z data provides upside catalyst
- RSI in optimal range for continuation
- Risk: FDA clinical hold on nex-z; recent patient death disclosure
- Next Earnings: February 26, 2026 (NO conflict)
4. CLSK - CleanSpark Inc. (BUY)
- Sector: Bitcoin Mining / AI Infrastructure
- Price: $13.72 | Beta: 3.80 | RSI: 62.5 | Short Interest: 29.97%
- Quantitative Score: 3.82/5.0 (75th percentile)
- Recent Catalyst: 587 BTC mined in Nov; AI/HPC pivot; JPMorgan upgrade to Overweight
- Why It Ranks #4:
- Very high short interest (30%) with Bitcoin breaking $100K
- AI data center pivot adds new growth narrative
- $1.15B convertible notes provide growth capital
- JPMorgan upgrade signals institutional interest
- Risk: Highly correlated with BTC price; crypto volatility
- Next Earnings: February 5, 2026 (NO conflict)
5. UPST - Upstart Holdings (BUY)
- Sector: Fintech (AI Lending)
- Price: $46.75 | Beta: 2.28 | RSI: 67.2 | Short Interest: 29.53%
- Quantitative Score: 3.67/5.0 (66th percentile)
- Recent Catalyst: $1.5B Castlelake forward-flow commitment; 71% YoY revenue growth
- Why It Ranks #5:
- High short interest (30%+) with positive fundamental story
- AI lending platform gaining traction
- New partnerships (Pathward, Peak Credit Union)
- Strong revenue growth trajectory
- Risk: Rate sensitivity; Q3 revenue miss caused recent pullback
- Next Earnings: February 10, 2026 (NO conflict)
6. WULF - TeraWulf Inc. (BUY)
- Sector: Bitcoin Mining / AI Infrastructure
- Price: $14.50 | Beta: 4.31 | RSI: 69.1 | Short Interest: 30.87%
- Quantitative Score: 3.61/5.0 (58th percentile)
- Recent Catalyst: $9.5B Fluidstack AI JV; Google $1.3B backing; preferred stock conversion Dec 9
- Why It Ranks #6:
- Major AI pivot with Google backing
- Preferred stock conversion Dec 9 may create near-term volatility
- Very high short interest (31%)
- Strong Q3 results (+87% YoY revenue)
- Risk: RSI approaching overbought (69); high debt levels; dilution from conversion
- Next Earnings: February 26, 2026 (NO conflict)
7. BEAM - Beam Therapeutics (SPECULATIVE BUY)
- Sector: Biotech (Base Editing)
- Price: $27.09 | Beta: 2.22 | RSI: 67.0 | Short Interest: 22.75%
- Quantitative Score: 3.48/5.0 (50th percentile)
- Recent Catalyst: ASH presentation Dec 6-9 with BEAM-101 sickle cell data
- EVENT TIMING: ASH conference runs Dec 6-9, 2025 - data presentation THIS WEEKEND
- Risk: Binary event risk from ASH data; biotech volatility
- Next Earnings: February 24, 2026 (NO conflict)
8-12. Additional Candidates (SPECULATIVE)
| Ticker |
Why Consider |
Key Risk |
| SYM |
$22.5B backlog; recent pullback creates entry |
Secondary offering dilution; -30% 1W momentum |
| MARA |
Highest beta (5.44); 2nd largest BTC holder |
Highly BTC-correlated; -26% 1M momentum |
| BE |
$5B Brookfield deal; 1000%+ 1Y return |
Extended valuation; profit-taking risk |
| HUT |
Extreme beta (6.21); BTC correlation play |
Lower short interest; recent weakness |
| CRSP |
Casgevy commercialization; CTX310 data |
Lower quant score; heavy short overhang |
Correlation Analysis & Portfolio Construction
WARNING: Highly Correlated Groups
Bitcoin Mining Cluster (r = 0.85):
- CLSK, WULF, MARA, HUT
- All move with Bitcoin - avoid holding more than 1-2 from this group
Biotech Cluster (r = 0.60):
- BEAM, NTLA, CRSP
- Shared gene editing sector risk - diversify exposure
Recommended 3-Position Portfolio (Budget: EUR 1,271.97)
For maximum diversification and risk-adjusted returns:
| Position |
Ticker |
Allocation |
EUR Amount |
Rationale |
| 1 |
ONDS |
40% |
EUR 508.79 |
Highest quant score; unique defense/drone exposure |
| 2 |
NVTS |
35% |
EUR 445.19 |
High squeeze potential; AI/semiconductor theme |
| 3 |
NTLA |
25% |
EUR 317.99 |
Highest short interest; biotech diversification |
Alternative Allocations:
Option B (More Aggressive):
- ONDS 35%, CLSK 35%, WULF 30% (BTC-heavy, maximum volatility)
Option C (Event-Driven):
- BEAM 40%, ONDS 35%, NVTS 25% (ASH catalyst + momentum plays)
Risk Management
Stop-Loss Recommendations
- Hard stop: -10% from entry (per user max loss tolerance)
- Trailing stop: 7% once position is +15%
Position Sizing by Risk
- Max single position: 40% of portfolio
- Max sector concentration: 50%
- Max correlated positions: 2 from same cluster
Key Dates to Monitor
- Dec 6-9: ASH Conference (BEAM catalyst)
- Dec 9: WULF preferred stock conversion
- Dec 8: SYM secondary offering closes
- Dec 18: FCEL earnings (EXCLUDED from list)
Data Sources
- Stock Data: yfinance (prices, technicals, fundamentals)
- Short Interest: yfinance, Finnhub API
- News & Catalysts: Web search (Benzinga, Yahoo Finance, StockTitan, Seeking Alpha)
- Quantitative Scoring: Custom factor model based on Elements of Quantitative Investing
Files Generated
/home/pengacau/pasar-malam/output/comprehensive_ultra_candidates.csv - Full screening results
/home/pengacau/pasar-malam/output/ultra_aggressive_final_candidates.json - Final 12 candidates with detailed data
/home/pengacau/pasar-malam/output/quant_factor_scores.json - Quantitative factor scoring results
/home/pengacau/pasar-malam/output/ultra_aggressive_screening_report_2025-12-06.md - This report
Disclaimer: This is a screening analysis for educational purposes. Ultra-aggressive trading strategies carry substantial risk of loss. Past performance does not guarantee future results. Always conduct your own due diligence before making investment decisions.